Drug resistance mutations in patients infected with HIV-2 living in Spain | Zendy

Ana Cecilia Treviño | Zendy; Carmen de Mendoza | Zendy; E. Caballero | Zendy; Carmen Rodríguez | Zendy; P. Parra | Zendy; Rafael Benito | Zendy; Teresa Cabezas | Zendy; Lourdes Roc | Zendy; Antonio Aguilera | Zendy; Vincent Soriano | Zendy; Jorge del Romero | Zendy; C. Tuset | Zendy; Goitzane Marcaida | Zendy; T. Tuset | Zendy; Irma Molina | Zendy; José Javier Rodríguez | Zendy; S. Cortizo | Zendy; Benito Regueiro | Zendy; M. Borrás | Zendy; Raúl Ortíz de Lejarazu | Zendy; José Marı́a Eiros Bouza | Zendy; Júlia Miró | Zendy; María López-Diéguez | Zendy; María Luisa Navarro Gómez | Zendy; Tomàs Pumarola | Zendy; J. Victor Garcia | Zendy; I. Paz | Zendy; Enrique J. Calderón | Zendy; Francisco J. Medrano | Zendy; M Leal | Zendy; F. Capote | Zendy; Alejandro Vallejo | Zendy; Fernando Dronda | Zendy; Santiago Moreno | Zendy; Domingo Escudero | Zendy; Emilio Pujol | Zendy; Matilde Trigo | Zendy; J. Diz | Zendy; Patrícia Álvarez | Zendy; Marta GarcíaCampello | Zendy; Manuel RodríguezIglesias | Zendy; A. M. Martin | Zendy; A. Hernández-Betancor | Zendy; José Manuel Ramos | Zendy; J. C. Rodriguez | Zendy; Félix Gutiérrez | Zendy; César Gómez-Hernando | Zendy; Ana Guelar | Zendy; Gustavo Cilla | Zendy; E Pérez-Trallero | Zendy; José LópezAldeguer | Zendy; J. Solá | Zendy; L. Fernandez-Pereira | Zendy; Jordí Niubó | Zendy; Sergio Veloso | Zendy; Alex Torres | Zendy; Ana María López Lirola | Zendy; José L. Gómez Sirvent | Zendy; Luís Force | Zendy; Celia Cifuentes | Zendy; S. Perez | Zendy; Caterina Olid Raya | Zendy; Alejandro GonzálezPraetorius | Zendy; Álvaro Mena | Zendy; José L. Pérez | Zendy; María Luz Pintos Peñaranda | Zendy; José Miguel Montejo | Zendy; Peré Domingo | Zendy; A. Martinez Sapina | Zendy; Isabel Viciana | Zendy; A. Lozano | Zendy; Juan Manuel Fernández | Zendy; Felipe García | Zendy; G. Gaspar | Zendy; Raúl López García | Zendy; Miguel Górgolas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug resistance mutations in patients infected with HIV-2 living in Spain

Author(s) -

Ana Cecilia Treviño,

Carmen de Mendoza,

E. Caballero,

Carmen Rodríguez,

P. Parra,

Rafael Benito,

Teresa Cabezas,

Lourdes Roc,

Antonio Aguilera,

Vincent Soriano,

Jorge del Romero,

C. Tuset,

Goitzane Marcaida,

T. Tuset,

Irma Molina,

José Javier Rodríguez,

S. Cortizo,

Benito Regueiro,

M. Borrás,

Raúl Ortíz de Lejarazu,

José Marı́a Eiros Bouza,

Júlia Miró,

María López-Diéguez,

María Luisa Navarro Gómez,

Tomàs Pumarola,

J. Victor Garcia,

I. Paz,

Enrique J. Calderón,

Francisco J. Medrano,

M Leal,

F. Capote,

Alejandro Vallejo,

Fernando Dronda,

Santiago Moreno,

Domingo Escudero,

Emilio Pujol,

Matilde Trigo,

J. Diz,

Patrícia Álvarez,

Marta GarcíaCampello,

Manuel RodríguezIglesias,

A. M. Martin,

A. Hernández-Betancor,

José Manuel Ramos,

J. C. Rodriguez,

Félix Gutiérrez,

César Gómez-Hernando,

Ana Guelar,

Gustavo Cilla,

E Pérez-Trallero,

José LópezAldeguer,

J. Solá,

L. Fernandez-Pereira,

Jordí Niubó,

Sergio Veloso,

Alex Torres,

Ana María López Lirola,

José L. Gómez Sirvent,

Luís Force,

Celia Cifuentes,

S. Perez,

Caterina Olid Raya,

Alejandro GonzálezPraetorius,

Álvaro Mena,

José L. Pérez,

María Luz Pintos Peñaranda,

José Miguel Montejo,

Peré Domingo,

A. Martinez Sapina,

Isabel Viciana,

A. Lozano,

Juan Manuel Fernández,

Felipe García,

G. Gaspar,

Raúl López García,

Miguel Górgolas

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr164

Subject(s) - resistance mutation , raltegravir , reverse transcriptase , virology , drug resistance , integrase , integrase inhibitor , hiv drug resistance , biology , dolutegravir , human immunodeficiency virus (hiv) , lentivirus , medicine , viral load , viral disease , gene , genetics , polymerase chain reaction , antiretroviral therapy

In contrast with HIV-1, information about drug resistance in HIV-2 is scarce and mainly derived from small series of patients failing antiretroviral therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research